Literature DB >> 8123867

Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.

E C Kordon1, A A Molinolo, C D Pasqualini, E H Charreau, P Pazos, G Dran, C Lanari.   

Abstract

We have demonstrated that medroxyprogesterone acetate (MPA), when administered in high doses, induces mammary carcinomas in virgin female BALB/c mice. Since one of the possible explanations for this effect was its progestagenic effects, we decided to investigate whether progesterone (Pg) alone could also induce mammary adenocarcinomas in our model and if MPA at doses lower than those used to establish the model was also carcinogenic. A total of 136 mice were subdivided into 3 groups: Group 1, 44 mice were implanted s.c. with 40 mg Pg silastic pellets at the beginning of the experiment, and 6 months later with a 20 mg Pg pellet; Group 2, 45 mice were similarly treated with MPA pellets; Group 3, 47 mice were inoculated s.c. with 40 mg MPA every three months. At the end of 20 months, 9 animals had developed mammary tumors in Group 1, 18 in Group 2 and 34 in Group 3 (actuarial incidence = 28%, 58%, and 98%, respectively); tumor latency was similar in all groups: 46.2 +/- 13.1, 51.3 +/- 9.9, and 50.1 +/- 2.1 weeks, respectively. Seven (Group 1), 14 (Group 2), and 25 (Group 3) tumors were transplanted into syngeneic mice to determine progestin dependence. All tumors, except one from Group 1, were histologically characterized. In Group 1 (Pg 60 mg), 4 tumors (67%) were infiltrating lobular carcinomas and 2 were ductal carcinomas (33%). In Group 2 (MPA 60 mg), 2 tumors (14%) were lobular and 12 were ductal adenocarcinomas (86%) (Group 1 vs Group 2: p < 0.05), whereas in Group 3 (MPA 160 mg), 8 were lobular carcinomas (32%) and 17 were ductal carcinomas (68%). In syngeneic passages all lobular tumors behaved as progestin independent (PI) and ductal tumors as progestin dependent (PD). All ductal tumors, except one, expressed estrogen receptors (ER) and progesterone receptors (PR), whereas receptor expression was variable in lobular carcinomas. It can be concluded that Pg induces mostly lobular, PI mammary tumors in BALB/c female mice. The fact that most MPA-induced tumors are ductal and PD suggests that the two hormones use different carcinogenic pathways.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8123867     DOI: 10.1007/bf00666353

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  29 in total

1.  Endocrine control of mammarygland development and function in the C3H/ He Crgl mouse.

Authors:  S NANDI
Journal:  J Natl Cancer Inst       Date:  1958-12       Impact factor: 13.506

2.  Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice.

Authors:  C Lanari; A A Molinolo; C D Pasqualini
Journal:  Cancer Lett       Date:  1986-11       Impact factor: 8.679

3.  Specific estrogen binding by the cytoplasm fof human breast carcinoma.

Authors:  S G Korenman; B A Dukes
Journal:  J Clin Endocrinol Metab       Date:  1970-05       Impact factor: 5.958

Review 4.  The sequential analysis of cancer development.

Authors:  E Farber; R Cameron
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

5.  Progesterone is not essential to the differentiative potential of mammary epithelium in the male mouse.

Authors:  C S Freeman; Y J Topper
Journal:  Endocrinology       Date:  1978-07       Impact factor: 4.736

6.  Hormone dependence of a mouse mammary tumor line induced in vivo by medroxyprogesterone acetate.

Authors:  E Kordon; C Lanari; R Meiss; P Elizalde; E Charreau; C Dosne Pasqualini
Journal:  Breast Cancer Res Treat       Date:  1990-11       Impact factor: 4.872

7.  Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones.

Authors:  J S Meyer
Journal:  Hum Pathol       Date:  1977-01       Impact factor: 3.466

8.  Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines.

Authors:  C Lanari; E Kordon; A Molinolo; C D Pasqualini; E H Charreau
Journal:  Int J Cancer       Date:  1989-05-15       Impact factor: 7.396

9.  Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice.

Authors:  H Nagasawa; M Aoki; N Sakagami; M Ishida
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  6 in total

Review 1.  Non-clinical studies of progesterone.

Authors:  R Sitruk-Ware
Journal:  Climacteric       Date:  2018-05-23       Impact factor: 3.005

Review 2.  The relevance of mouse models to understanding the development and progression of human breast cancer.

Authors:  D Craig Allred; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-08-14       Impact factor: 2.673

3.  Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates.

Authors:  Thu H Truong; Amy R Dwyer; Caroline H Diep; Hsiangyu Hu; Kyla M Hagen; Carol A Lange
Journal:  Endocrinology       Date:  2019-02-01       Impact factor: 4.736

4.  Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice.

Authors:  Caroline A Lamb; Luisa A Helguero; Sebastián Giulianelli; Rocío Soldati; Silvia I Vanzulli; Alfredo Molinolo; Claudia Lanari
Journal:  Breast Cancer Res       Date:  2005-11-09       Impact factor: 6.466

Review 5.  Progesterone receptors--animal models and cell signalling in breast cancer. Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer.

Authors:  Claudia Lanari; Alfredo A Molinolo
Journal:  Breast Cancer Res       Date:  2002-09-12       Impact factor: 6.466

6.  Association of estrogen receptor-alpha and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment.

Authors:  Guadalupe Montero Girard; Silvia I Vanzulli; Juan Pablo Cerliani; María Cecilia Bottino; Julieta Bolado; Jorge Vela; Damasia Becu-Villalobos; Fernando Benavides; Silvio Gutkind; Vyomesh Patel; Alfredo Molinolo; Claudia Lanari
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.